Your session is about to expire
← Back to Search
Topical Gel
LEV102 Topical Gel, 2.0% for Droopy Eyelid
Phase 1 & 2
Waitlist Available
Research Sponsored by Levation Pharma, Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 2-5
Summary
This trial tests a one-time application of a special medicine on the upper eyelids of adults with drooping eyelids. The goal is to see if the medicine can lift the eyelids. About 30 participants will be involved.
Eligible Conditions
- Droopy Eyelid
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 2-5
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 2-5
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability])
Secondary study objectives
Upper eyelid height
Trial Design
3Treatment groups
Experimental Treatment
Placebo Group
Group I: LEV102 Topical Gel, 2.0%Experimental Treatment1 Intervention
Group II: LEV102 Topical Gel, 1.0%Experimental Treatment1 Intervention
Group III: VehiclePlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
LEV102 1.0%
2023
Completed Phase 2
~40
LEV102 2.0%
2023
Completed Phase 2
~40
Find a Location
Who is running the clinical trial?
Levation Pharma, Ltd.Lead Sponsor
Houman D Hemmati, MD PhDStudy ChairLevation Pharma, Ltd.
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You want to lift your upper eyelids because you don't like how they look or they are affecting your ability to see properly.You should not have any eye conditions other than ptosis that require prescription eye drops (like glaucoma or dry eye).You should not have certain eye conditions like narrow angles, glaucoma, or high intraocular pressure. You should also not have had certain eye surgeries in the past.
Research Study Groups:
This trial has the following groups:- Group 1: LEV102 Topical Gel, 2.0%
- Group 2: LEV102 Topical Gel, 1.0%
- Group 3: Vehicle
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger